BEACOPP-14 VS BEACOPP-ESC IN PATIENTS WITH HODGKIN'S LYMPHOMA FROM POOR-PROGNOSIS GROUP: PRELIMINARY RESULTS OF PROSPECTIVE RANDOMIZED MULTYCENTER STUDY

被引：0
|
作者：
Kriachok, I. [1 ]
Titorenko, I. [1 ]
Filonenko, K. [1 ]
Aleksik, E. [1 ]
Novosad, O. [1 ]
Kadnikova, T. [1 ]
Kushchevoy, E. [1 ]
Martinchik, A. [1 ]
Pastushenko, Y. [1 ]
机构：
[1] Natl Canc Inst, Kiev, Ukraine
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1366
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [41] Improved outcome of elderly patients with poor-prognosis diffuse large B-cell lymphoma (DLBCL) after dose-dense rituximab: Results of the DENSE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
    Pfreundschuh, M.
    Zeynalova, S.
    Poeschel, V.
    Haenel, M.
    Schmitz, N.
    Ho, A. D.
    Reiser, M.
    Loeffler, M.
    Schubert, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Intensified induction followed by high-dose therapy with autologous peripheral blood stem cell support in poor-prognosis aggressive non-Hodgkin's lymphoma: results of a pilot study
    Choi, SJ
    Ryoo, BY
    Lee, SS
    Park, YH
    Kim, BS
    Kang, YK
    HAEMATOLOGICA, 2002, 87 (05) : 555 - 557
  • [43] A comparison of outcome and second malignancies in adolescents and adult patients with Hodgkin's lymphoma (HL). Results from the German Hodgkin study group.
    Bredenfeld, H
    Gilman, E
    Pfistner, B
    Diehl, V
    Engert, A
    BLOOD, 2005, 106 (11) : 749A - 749A
  • [44] Improved Outcome of Elderly Poor-Prognosis DLBCL Patients with 6xCHOP-14 and 8 Applications of Rituximab (R) Given Over An Extended Period: Results of the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
    Pfreundschuh, Michael
    Held, Gerhard
    Zeynalova, Samira
    Poeschel, Viola
    Viardot, Andreas
    Haenel, Matthias
    Keller, Ulrich
    Reiser, Marcel
    Loeffler, Markus
    Murawski, Niels
    BLOOD, 2011, 118 (21) : 272 - 273
  • [45] Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study
    Bosly, A
    Lepage, E
    Coiffier, B
    Dupriez, B
    Herbrecht, R
    Fillet, G
    Divine, M
    Nouvel, C
    Tilly, H
    Bordessoule, D
    Gaulard, P
    Gisselbrecht, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 546 - 546
  • [46] Cyclosporin A - Can it be effectively given from the day of stem cell return in patients with poor-prognosis non-Hodgkin's lymphoma undergoing high dose chemotherapy with peripheral stem cell transplantation.
    Dobson, LS
    Duggan-Keen, M
    Radford, JA
    Stern, PL
    Morgenstern, GR
    Scarffe, HJ
    Crowther, D
    BRITISH JOURNAL OF CANCER, 1998, 78 : 41 - 41
  • [47] VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the non-Hodgkin's lymphoma cooperative study group
    Santini, G
    Salvagno, L
    Leoni, P
    Chisesi, T
    De Souza, C
    Sertoli, MR
    Rubagotti, A
    Congiu, AM
    Centurioni, R
    Olivieri, A
    Tedeschi, L
    Vespignani, M
    Nati, S
    Soracco, M
    Porcellini, A
    Contu, A
    Guarnaccia, C
    Pescosta, N
    Majolino, I
    Spriano, M
    Vimercati, R
    Rossi, E
    Zambaldi, G
    Mangoni, L
    Endrizzi, L
    Sileni, VC
    Miggiano, MC
    Marino, G
    Damasio, E
    Rizzoli, V
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2796 - 2802
  • [48] Therapy of HIV-related non-Hodgkin's lymphoma: An European multicentric randomized study in patients stratified according to their prognostic factors: Preliminary results.
    Gisselbrecht, C
    Spina, M
    Gabarre, J
    Rizzardini, G
    Schlaifer, D
    Nigra, E
    Bouabdallah, R
    Schrappe, M
    Rapoport, B
    Carbone, C
    Raphael, M
    Tirelli, U
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : 149 - 149
  • [49] Quality control of involved-field radiotherapy for patients with early stage Hodgkin's lymphoma based on a central prospective review Comparison of the results between two study generations of the German Hodgkin Study Group
    Kriz, J.
    Bangard, C.
    Haverkamp, U.
    Bongartz, R.
    Baues, C.
    Engert, A.
    Mueller, R-P
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (08) : 660 - 665
  • [50] ROLE OF INTERIM-PET IN POOR PROGNOSIS YOUNG PATIENTS WITH DLBC LYMPHOMA AT DIAGNOSIS: DATA FROM A PROSPECTIVE ANCILLARY STUDY OF A RANDOMIZED PHASE III STUDY FROM THE FONDAZIONE ITALIANA LINFOMI
    Rigacci, L.
    Pregno, P.
    Puccini, B.
    Evangelista, A.
    Chiappella, A.
    Gaidano, G.
    Nassi, L.
    Balzarotti, M.
    Merli, F.
    De Renzo, A.
    Levis, A.
    Spina, M.
    Pavone, V.
    Freilone, R.
    Luminari, S.
    Rossi, G.
    Stelitano, C.
    Carella, A. M.
    D'Arco, A. M.
    Musto, P.
    Kovalchuk, S.
    Benelli, G.
    Bosi, A.
    Vitolo, U.
    HAEMATOLOGICA, 2014, 99 : 412 - 412
12345